HOUSTON, TX — January 15, 2025 — Houston MedTech Partners, a healthcare technology investment and development firm, today announced the successful close of a $25 million Series B funding round led by Gulf Coast Ventures, with participation from Austin-based Spur Capital and existing investors. The company plans to deploy the capital across three primary areas: expanding its portfolio of early-stage medical device companies, scaling its proprietary clinical development platform, and recruiting senior talent across engineering and regulatory affairs. Houston MedTech Partners currently supports 14 portfolio companies focused on cardiovascular diagnostics, minimally invasive surgical tools, and remote patient monitoring technologies. "This funding validates what our team has built over the past five years and positions us to move faster on opportunities that can genuinely improve patient outcomes," said CEO Dr. Mara Chen. "Houston's medical corridor gives us unmatched proximity to world-class clinical partners, and we intend to use that advantage aggressively." The raise comes amid sustained investor interest in medtech, with the sector attracting approximately $14 billion in venture funding nationally in 2024, according to MedTech Dive. Houston MedTech Partners reported a 40% increase in portfolio revenue year-over-year heading into the new funding cycle. The company expects to announce two new portfolio additions by the second quarter of 2025. **About Houston MedTech Partners:** Houston MedTech Partners is a Houston-based healthcare technology firm that invests in and develops early-stage medical device and diagnostics companies. Founded in 2019, the company operates within the Texas Medical Center ecosystem and manages a portfolio of 14 active companies across multiple therapeutic areas. For more information, visit houstonmedtechpartners.com. ---